Endpoints News ٦ أبريل ٢٠٢٦ Stipple Bio launches with $100M to find more precise targets on cancer proteins
Endpoints News ٤ أبريل ٢٠٢٦ Pharma’s dealmaking tear; Blackstone raises record fund; Xolair energizes allergy research; and more
Endpoints News ٢ أبريل ٢٠٢٦ Trump signs order to put 100% pharma tariffs on drugs, countries without trade deals
Endpoints News ٢ أبريل ٢٠٢٦ Aspect Biosystems gets $79M from Canadian government for diabetes cell therapy
Endpoints News ٢ أبريل ٢٠٢٦ Novo and Lilly battle over GLP-1 claims only a head-to-head trial can answer
Endpoints News ٢ أبريل ٢٠٢٦ Drug substance maker raises prices due to energy crisis; SpectronRX gets $85M
Endpoints News ٢ أبريل ٢٠٢٦ Lipocine's postpartum depression drug fails; AstraZeneca claims liver cancer win
Endpoints News ٢ أبريل ٢٠٢٦ Alto Neuroscience shelves schizophrenia cognitive impairment program after Phase 2 miss
Endpoints News ٢ أبريل ٢٠٢٦ Eli Lilly's chief technology officer retires after 35 years; Astellas strategy exec resigns
Endpoints News ٢ أبريل ٢٠٢٦ Immunovant's FcRn drug fails in a pair of Phase 3 trials in thyroid eye disease